Bio-Works Technologies

Bio-Works Technologies Equity

The The Equity of Bio-Works Technologies (BIOWKS.SL) as of Oct 12, 2026 is 49.21 M SEK. In the previous year, The Equity was 44.58 M SEK — a change of 10.37% (higher).

Equity

49.21 MSEK

YoY

10.37%

Last updated:

In 2025, Bio-Works Technologies's equity was 49.21 M SEK, a 10.37% increase from the 44.58 M SEK equity in the previous year.

The Bio-Works Technologies Equity history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Equity
Date
Equity
Jan 1, 2018
61.64 M SEK
Jan 1, 2019
82.13 M SEK
Jan 1, 2020
37.46 M SEK
Jan 1, 2021
108.51 M SEK
Jan 1, 2022
67.69 M SEK
Jan 1, 2023
44.03 M SEK
Jan 1, 2024
44.58 M SEK
Jan 1, 2025
49.21 M SEK
The Bio-Works Technologies Equity history
YEAREquityYoY
49.21 MSEK+10.37%
44.58 MSEK+1.25%
44.03 MSEK-34.95%
67.69 MSEK-37.62%
108.51 MSEK+189.69%
37.46 MSEK-54.39%
82.13 MSEK+33.24%
61.64 MSEK-37.93%
99.32 MSEK+320.10%
23.64 MSEK+5.50%
22.41 MSEK—
Access this data via the Eulerpool API
Get Free API Key

Bio-Works Technologies Stock analysis

What does Bio-Works Technologies do? Bio-Works Technologies is one of the most popular companies on Eulerpool.

Equity Details

Analyzing Bio-Works Technologies's Equity

Bio-Works Technologies's equity represents the ownership interest in the company, calculated as the difference between total assets and total liabilities. It reflects the residual claim by shareholders on the company’s assets after all debts have been paid. Understanding Bio-Works Technologies's equity is essential for assessing its financial health, stability, and value to shareholders.

Year-to-Year Comparison

Evaluating Bio-Works Technologies's equity over successive years offers insights into the company's growth, profitability, and capital structure. Increasing equity indicates an enhancement in net assets and financial health, while decreasing equity could point to rising debts or operational challenges.

Impact on Investments

Bio-Works Technologies's equity is a crucial element for investors, influencing the company's leverage, risk profile, and return on equity (ROE). Higher equity levels generally suggest lower risk and enhanced financial stability, making the company a potentially attractive investment opportunity.

Interpreting Equity Fluctuations

Fluctuations in Bio-Works Technologies’s equity can arise from various factors, including changes in net income, dividend payments, and issuance or buyback of shares. Investors analyze these shifts to gauge the company's financial performance, operational efficiency, and strategic financial management.

Frequently Asked Questions about Bio-Works Technologies stock

The Equity of Bio-Works Technologies is 49.21 M SEK in 2025.

The Equity of Bio-Works Technologies changed from 44.58 M SEK to 49.21 M SEK, representing a 10.37% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of The Equity Bio-Works Technologies since 2006 – with annual values, charts, and detailed analysis.

The Equity's SEK is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track The Equity's Bio-Works Technologies historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Balance Sheet — Bio-Works Technologies

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Bio-Works Technologies